Chemours (CC) PT Lowered to $14 at RBC Capital

Go back to Chemours (CC) PT Lowered to $14 at RBC Capital

Chemours (CC) PT Lowered to $11.50 at Jefferies

May 8, 2025 12:55 PM EDT

Jefferies analyst Laurence Alexander lowered the price target on Chemours (NYSE: CC) to $11.50 (from $20.00) while maintaining a Hold rating.

The analyst comments "Q1 EPS of $0.13 was $0.07 below consensus and $0.21 below our estimate. Supply chain distortions appear to be a near-term headwind, while a... More